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Background: GABAergic deficit is one of the major mechanisms underlying epileptic seizures. Previous studies have
mainly focused on alterations of synaptic GABAergic inhibition during epileptogenesis. Recent work suggested that
tonic inhibition may also play a role in regulating epileptogenesis, but the underlying mechanism is not well
understood.
Results: We employed molecular and pharmacological tools to investigate the role of tonic inhibition during
epileptogenesis both in vitro and in vivo. We overexpressed two distinct subtypes of extrasynaptic GABAA receptors,
α5β3γ2 and α6β3δ receptors, in cultured hippocampal neurons. We demonstrated that overexpression of both
α5β3γ2 and α6β3δ receptors enhanced tonic inhibition and reduced epileptiform activity in vitro. We then showed
that injection of THIP (5 μM), a selective agonist for extrasynaptic GABAA receptors at low concentration, into rat
brain also suppressed epileptiform burst activity and behavioral seizures in vivo. Mechanistically, we discovered that
low concentration of THIP had no effect on GABAergic synaptic transmission and did not affect the basal level of
action potentials, but significantly inhibited high frequency neuronal activity induced by epileptogenic agents.
Conclusions: Our studies suggest that extrasynaptic GABAA receptors play an important role in controlling
hyperexcitatory activity, such as that during epileptogenesis, but a less prominent role in modulating a low level of
basal activity. We propose that tonic inhibition may play a greater role under pathological conditions than in
physiological conditions in terms of modulating neural network activity.
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Many antiepileptic drugs are targeting GABAergic synap-
tic transmission, but may cause certain side effects [1,2].
GABAA receptors (GABAA-Rs) are abundant not only at
synaptic sites, but also at extrasynaptic sites. Synaptic
GABAA-Rs have low affinity for GABA, are activated in a
transient manner by GABA released form presynaptic ves-
icles, and primarily mediate phasic inhibitory transmis-
sion. In contrast, extrasynaptic GABAA-Rs exhibit high
affinity for GABA, are persistently activated by low con-
centration of ambient GABA, and mediate tonic inhibition
[3-5]. There are two distinct subtypes of extrasynaptic* Correspondence: yunwang@fudan.edu.cn; gongchen@psu.edu
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reproduction in any medium, provided the orGABAA-Rs in the brain, one contains the α5 subunit
[6-10] and the other contains the δ subunit [11-13]. The
α5-GABAA-Rs are sensitive to a specific inverse agonist
L-655,708 [14,15], while the δ-GABAA-Rs are typically
insensitive to benzodiazepine [16,17] but highly sensi-
tive to THIP (gaboxadol) [18,19].
Functional deficit of synaptic GABAergic inhibition
plays an important role in the etiology of epilepsy
[2,20-22]. Recent studies revealed a possible role of
tonic inhibition in modulating epileptic seizures [23,24].
A significant reduction of GABAA-R α5 and δ subunit
level has been reported in the hippocampus of animals
with temporal lobe epilepsy (TLE) [8,25,26]. Interest-
ingly, the decrease of δ subunit may be compensated by
an increase of α4 and γ2 subunits [26-28]. Mutations in
the δ subunit of GABAA-Rs have been mapped in
human epilepsy patients [29,30]. Increased δ subunit
level during diestrus stage of ovarian cycle has been. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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induced epilepsy models [31]. However, in the pyramidal
neurons of hippocampal CA1 region, the α5 GABAA-R
mediated tonic current was reduced but overall tonic in-
hibition was not changed or even increased in pilocarpine
epilepsy model [32]. Furthermore, enhanced tonic inhib-
ition in thalamocortical neurons was reported to induce
absence seizure [33], suggesting that different tonic inhib-
ition may play different roles in different brain regions.
Here we investigated the functional role of two dis-
tinctly different subtypes of extrasynaptic GABAA-Rs
in hippocampal epileptogenesis. We demonstrated that
enhancing tonic inhibition by overexpressing either the
α5β3γ2 or α6β3δ extrasynaptic GABAA receptors sig-
nificantly inhibited the formation of epileptiform activity
in hippocampal cultures. Furthermore, in vivo injection of
selective extrasynaptic GABAA-R agonist THIP also
inhibited epileptiform bursting activity in anesthetized rats
and seizure behaviors in freely moving rats. Interestingly,
low concentration of THIP did not affect basal level of
neuronal activity, but significantly suppressed higher fre-
quency neuronal firing. Therefore, our data suggest that
tonic inhibition mediated by extrasynaptic GABAA-Rs
may play a more prominent function in pathological con-
ditions such as during epileptogenesis.
Results
Molecular enhancement of tonic GABA currents after
overexpressing α5β3γ2 GABAA receptors
We have previously demonstrated that epileptiform
activity downregulates tonic inhibition mediated by
extrasynaptic GABAA receptors [34]. In this study, we
investigated the effect of enhanced tonic inhibition on epi-
leptiform activity. The majority of extrasynaptic GABAA
receptors (GABAA-Rs) can be categorized into two dis-
tinct subtypes, containing either the α5 or the δ subunit.
The α5-GABAA-Rs are mainly expressed in the hippo-
campus of adult brain, while δ-GABAA-Rs are mostly
expressed in dentate and cerebellar granule cells as well
as in the thalamus. To understand which subtype of
extrasynaptic GABAA-Rs may affect epileptiform activity,
we overexpressed both the α5β3γ2 and α6β3δ GABAA-Rs
in hippocampal neurons to enhance tonic inhibition and
tested their effects on epileptiform activity. Since α5
subunit is normally expressed in hippocampal pyram-
idal neurons [6], we first tested the effect of α5β3γ2 re-
ceptors on epileptiform activity. We have tested several
α5 subunits and found a right one that can give large
GABA-evoked current when coexpressed with the β3
and γ2 subunits in HEK 293T cells (Figure 1A). The
inverse agonist L-655,708 (100 nM) specific for the α5
subunit significantly inhibited the GABA-evoked cur-
rents (Figure 1A-B; Control, 437 ± 63 pA, n = 10; L-655,
708, 143 ± 26 pA, n = 10; ***, p < 0.001; Student’s t test),confirming that the GABA current was mediated by α5
subunit-containing GABAA-Rs. We next overexpressed
the α5β3γ2 receptors in cultured hippocampal pyramidal
neurons. The GABA-evoked whole-cell currents appeared
to be similar between neurons transfected with the α5β3γ2
receptors and the mCherry for control (Figure 1C-D;
mCherry, 3380 ± 408 pA, n =13; α5β3γ2, 3646 ± 518
pA, n = 14; p > 0.5). However, tonic GABA currents
revealed by acute application of GABAA-R blocker
bicuculline (Bic, 40 μM; together with 1 μM TTX and
10 μM DNQX) [9,34,35], were significantly increased
in α5β3γ2-transfected neurons compared to mCherry-
transfected control neurons (Figure 1E-F; mCherry, 13.1 ±
1.7 pA, n = 8; α5β3γ2, 24.5 ± 4.2 pA, n = 8; p < 0.05). These
data demonstrated that overexpression of the α5β3γ2 re-
ceptors enhanced tonic GABA currents in hippocampal
neurons.
Tonic inhibition mediated by the α5β3γ2 receptors
suppresses epileptiform activity
We further tested whether epileptiform activity was af-
fected by the enhanced tonic GABA current in neurons
overexpressing the α5β3γ2 receptors. We previously
established a unique cyclothiazide (CTZ) induced epi-
lepsy model both in vitro and in vivo [36-39]. The ad-
vantage of CTZ model is its reliability in inducing
epileptiform activity without significant cell death [36].
We treated hippocampal culture with CTZ (5 μΜ, 24 hr)
to induce epileptiform activity, similar to reported before
[36]. Control neurons transfected with mCherry showed
robust epileptiform activity after CTZ-treatment, with a
train of high-frequency action potentials overlaying on
the plateau of large depolarization shifts (Figure 2A). In
contrast, the majority of neurons transfected with the
α5β3γ2 receptors did not show clear epileptiform acti-
vity, except some sparse action potentials on top of
small depolarization bursts (Figure 2B). Quantitatively,
about 90% of control neurons showed epileptiform activity
after CTZ-treatment (26 out of 29 neurons), whereas only
about 33% of neurons transfected with the α5β3γ2 recep-
tors showed epileptiform activity (11 out of 33 neurons)
(Figure 2C). The average frequency of epileptiform bursts
was also significantly reduced in α5β3γ2-transfected neu-
rons (Figure 2D; mCherry, 1.83 ± 0.35 per min, n = 29;
α5β3γ2, 0.49 ± 0.16 per min, n = 33; p < 0.001). Together,
our experiments demonstrated that enhanced tonic in-
hibition mediated by the α5β3γ2 receptors significantly
suppressed the formation of epileptiform activity in hippo-
campal neurons.
Inhibition of epileptiform activity by the α6β3δ receptors
We next examined a distinctly different subtype of extra-
synaptic GABAA-Rs, the α6β3δ receptors [11,12], in the
regulation of epileptiform activity. We first examined
Figure 1 Tonic GABA current increased after the overexpression of α5β3γ2 GABAA receptors. A, Typical GABA (100 μM) induced currents
in HEK293T cells transfected with α5β3γ2 subunits (left panel), which could be largely blocked by α5 subunit-specific inverse agonist L655,708
(100 nM, right panel). B, Summarized data showing GABA-induced α5β3γ2 receptor currents in HEK293T cells significantly inhibited by L655,708
(Control, 437.1 ± 63.1 pA, n = 10; L655,708, 142.8 ± 25.7 pA, n = 10; ***, p < 0.001). C, Typical GABA current traces in cultured hippocampal
neurons transfected with mCherry or plus the α5β3γ2 subunits. D, Bar graphs showing no significant difference between the total whole-cell
GABA currents in neurons transfected with mCherry or plus the α5β3γ2 subunits. E, Representative tonic GABA currents revealed by rapid
application of GABAA-R blocker bicuculline (100 μM) in hippocampal neurons transfected with mCherry or plus the α5β3γ2 subunits. F, Summarized
data showing that tonic GABA current in α5β3γ2-transfected neurons (24.5 ± 4.2 pA, n = 8) was significantly increased in comparison with the
control neurons (13.1 ± 1.7 pA, n = 8; *, p < 0.05).
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receptors in hippocampal cultures. GABA-evoked whole-
cell currents showed no difference between GFP- and
α6β3δ-transfected neurons (Figure 3A). Quantitatively,
the average GABA-evoked current in α6β3δ-transfected
neurons was 3327 ± 206 pA (n = 10), which was not sig-
nificantly different from the GFP control (3967 ± 328 pA,
n = 10, p > 0.1; Figure 3B). To confirm functional expres-
sion of the α6β3δ receptors in hippocampal neurons, we
examined tonic GABA current after Bic treatment and
found that the tonic GABA current was greatly increased
in α6β3δ-transfected neurons (Figure 3C). Quantitatively,
the average amplitude of tonic GABA currents in α6β3δ-transfected neurons was 28.1 ± 3.6 pA (n = 10), signifi-
cantly larger than that of control neurons (7.4 ± 1.1 pA,
n = 11, p < 0.0001) (Figure 3D). Furthermore, we employed
THIP (5 μM), a relatively specific agonist for δ subunit
containing GABAA-Rs at low concentration, to investigate
tonic currents in control and α6β3δ-transfected neurons.
THIP activated a small non-desensitizing tonic current in
GFP-transfected neurons, accompanied with an increase
of the baseline noise (Figure 3E, top trace). In α6β3δ-
transfected neurons, however, the THIP-induced tonic
current was markedly increased (Figure 3E, bottom trace).
The average amplitude of THIP current in control neu-
rons was 35.3 ± 7.4 pA (n = 11), and greatly increased to
Figure 2 Inhibition of epileptiform activity in cultured hippocampal neurons overexpressing α5β3γ2 receptors. A, Typical traces from
two hippocampal neurons showing the epileptiform burst activity after chronic CTZ treatment (5 μΜ, 24 h). Panel b shows the expanded view of a
single epileptiform burst from panel a. Epileptiform burst is characterized by a train of action potentials on a large depolarization shift. B, Representative
traces showing the lack of epileptiform bursts in two hippocampal neurons transfected with the α5β3γ2 receptors. C, Bar graphs illustrating
that overexpression of α5β3γ2 receptors significantly reduced the percentage of neurons showing epileptiform activity after chronic CTZ
treatment (mCherry, ~90%, n = 29; α5β3γ2, ~33%, n = 33; ***, p < 0.001). D, Neurons transfected with α5β3γ2 receptors showing lower burst
frequency (0.49 ± 0.16 per min, n = 33), compared to mCherry controls after CTZ treatment (1.83 ± 0.35 per min, n = 29; ***, p < 0.001).
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p < 0.0001; Figure 3F). Thus, overexpression of α6β3δ
receptors in hippocampal neurons significantly increased
tonic GABA currents, similar to the overexpression of
α5β3γ2 receptors.
We then examined whether overexpression of the
α6β3δ receptors has any effect on epileptiform activity. In
GFP-transfected control neurons, CTZ-treatment (5 μΜ,
24 hr) induced robust epileptiform activity as expected
(Figure 4A). In contrast, hippocampal neurons transfected
with α6β3δ receptors showed a significant attenuation
of epileptiform activity (Figure 4B). Quantitatively, thepercentage of neurons displaying epileptiform activity was
84% (21 out of 25) in GFP-transfected controls, but re-
duced to 31% (9 out of 29) in α6β3δ-transfected neurons
(Figure 4C; p < 0.001). Furthermore, the frequency of
epileptiform bursts in α6β3δ-transfected neurons also
reduced significantly (0.56 ± 0.2 bursts per min, n = 29,
p < 0.003), compared to that in GFP control neurons
(1.64 ± 0.28 bursts per min, n = 25) (Figure 4D). We in-
vestigated whether the overexpression of extrasynaptic
GABAA-Rs would alter neuronal intrinsic properties,
but found no changes in resting membrane potential
(mCherry, -52.3 ± 1.3 mV, n = 15; α5β3γ2, -50.1 ± 1.6 mV,
Figure 3 Overexpression of α6β3δ subunits results in large tonic GABA current in cultured hippocampal neurons. A, Typical recordings
showing whole-cell currents induced by rapid application of GABA (20 μM) in GFP control and α6β3δ-transfected neurons in the presence of TTX
(1 μM) and DNQX (10 μM). B, Summarized data showing no significant difference in whole-cell GABA currents between the two groups. C, Typical
traces of tonic GABA currents, revealed by application of Bic (40 μM) in the presence of TTX (1 μM) and DNQX (10 μM), recorded from a GFP
control neuron and a α6β3δ-transfected neuron. Holding potential = −70 mV. D, Summarized data showing that the average amplitude of
tonic GABA currents was significantly increased in α6β3δ-transfected neurons (28.1 ± 3.6 pA, n = 10), compared to the GFP controls (7.4 ± 1.1 pA,
n = 11; ***, p < 0.0001). E, Tonic currents activated by THIP (5 μM) in GFP control and α6β3δ-transfected neurons. F, Summarized data showing a
significant increase of THIP-induced tonic currents after transfection of α6β3δ subunits (962 ± 130 pA, n = 12), compared to the GFP controls (35.3 ±
7.4 pA, n = 11; ***, p < 0.0001).
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ANOVA), membrane resistance (mCherry, 204 ± 22 MΩ,
n = 15; α5β3γ2, 177 ± 17 MΩ, n = 12; α6β3δ, 237 ±
24 MΩ, n = 10; p > 0.4), or membrane capacitance
(mCherry, 96.3 ± 7.8 pF, n = 15; α5β3γ2, 114.6 ± 10.8 pF,
n = 12; α6β3δ, 95.7 ± 16.1 pF, n = 10; p > 0.19) in different
transfected groups. Together, our data demonstrated that
both α6β3δ and α5β3γ2 extrasynaptic GABAA-Rs have an
important role in regulating hippocampal epileptogenesis
in vitro.Tonic inhibition on in vivo epileptic seizures
After performing in vitro studies, we decided to further
investigate the effect of tonic inhibition on epileptiform
activity in in vivo condition. We recorded field poten-
tials in the hippocampal CA1 pyramidal layer from 5
urethane-anaesthetized rats. In all 5 rats studied, the
evoked responses following low frequency stimulation
of CA3 region consisted of a large EPSP and a single
population spike (PS) during control recordings (data
not shown, see [36]), and the baseline activity was virtually
Figure 4 Overexpression of α6β3δ receptors inhibits epileptiform bursting activity in cultured hippocampal neurons. Aa, Representative
traces showing the typical recurrent epileptiform bursts after chronic pretreatment with CTZ (5 μM, 24 h) in two different GFP-transfected
pyramidal neurons. Ab, A single epileptiform burst in (a) was expanded to show a train of action potentials overlaying on a large depolarization
shift. Ba, Representative traces showing the lack of typical epileptiform bursts in two α6β3δ-transfected hippocampal neurons. Bb, Expanded
view of the boxed activity in (a). C, Bar graph showing the percentage of neurons with epileptiform bursting activity after chronic treatment with
CTZ (5 μM for 24 h). *** p < 0.001, Pearson Chi-Square test. D, Bar graph showing a significant reduction of the average epileptiform burst
frequency in neurons transfected with α6β3δ receptors, comparing to GFP controls after CTZ treatment. ** p < 0.01.
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(i.c.v.) injection of CTZ (5 μmol in 5 μl), the single-
peaked PS gradually transformed into a multiple-peaked
event and the spontaneous recurrent epileptiform
bursts were stable for at least 30 min in all 5 rats tested
(Figure 5Ab). To enhance tonic inhibition in vivo, we
chose to use agonist specific for extrasynaptic GABAA-
Rs. For the α5 subunit-containing GABAA-Rs, there is
no specific agonist available except inverse agonists that
reduce receptor responses. However, THIP at low con-
centration is a selective agonist for the δ subunit-
containing GABAA-Rs and widely used to elicit tonicinhibition both in vitro and in vivo [40-43]. Therefore,
we delivered THIP (4 mg/kg) through the cannula pre-
implanted in the lateral tail vein after the induction of
epileptiform activity. Compared with the epileptiform
burst number (7.2 ± 1.0 per 30 min) before THIP injec-
tion, the mean burst number after THIP administration
was significantly reduced to 0.8 ± 0.4 (p < 0.003) over a
30 min analysis period (Figure 5Ac). Interestingly, the
inhibitory effect of THIP on epileptiform activity was
reversible, as indicated by a gradual increase of the
mean burst number (2.0 ± 0.7 per 30 min) during a
prolonged recovery period after the THIP injection
Figure 5 THIP inhibits CTZ-induced epileptiform activity and seizure behavior. Aa-d, Typical traces showing ‘silent’ baseline activity of
hippocampal CA1 neurons in control condition (a), synchronized epileptiform bursting activities induced by CTZ (5 μmol) (b), inhibition of THIP (4
mg /kg) on burst activity (c), and the recovery after the THIP injection (d). Ae, Bar histogram showing group data of THIP inhibition on CTZ-
induced epileptiform burst activities. B, Bar histogram showing group data of CTZ-induced (5 μmol) seizure behavioral score and its significant
attenuation by pre-treatment with THIP (10 mg/kg). THIP(5): 5 mg/kg THIP; THIP(10): 10 mg/kg THIP. * p < 0.05 and ** p < 0.01 in comparison
with CTZ injection alone; # p < 0.05 for recovery, in comparison with CTZ + THIP.
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of CTZ, CTZ + THIP, and the recovery group was sum-
marized in Figure 5Ae. These results indicate that acute
application of THIP in in vivo condition can effectively
suppress epileptiform activity.
Besides epileptiform activity, we further studied
whether THIP can directly modulate CTZ-induced
seizure behavior in freely moving rats [38]. CTZ was
injected repeatedly each day (0.25 μmol i.c.v. for 3 con-
secutive days, total dose of 0.75 μmol) to induce seizure
behavior without or with a pre-injection of THIP. The
administration of THIP (5 or 10 mg/kg, i.p.) at 10 min
before CTZ injection dose-dependently attenuated the
convulsant seizures induced by CTZ. The seizure score
was 4.5 ± 0.3 (n = 6) after CTZ injection alone, and
significantly reduced to 2.6 ± 0.7 (n = 7) in THIP-
preinjected (10 mg/kg) animals (p < 0.05; Figure 5B).
The lower dose of THIP pretreatment (5 mg/kg) also
reduced seizure score but not reaching statistical signifi-
cance. Therefore, THIP may be used as a potential anti-
convulsant drug to suppress seizure behaviors in living
animals.Tonic inhibition and basal GABAergic neurotransmission
While previous studies have linked tonic inhibition with
seizure threshold [31,44], the underlying mechanism is
not fully understood. We decided to investigate the mech-
anism of tonic inhibition in regulating epileptiform activ-
ity. One question we addressed is whether tonic inhibition
has any direct effect on basal GABAergic synaptic
transmission in rat hippocampal cultures. Spontaneous
miniature inhibitory postsynaptic currents (mIPSCs)
were recorded in the presence of TTX (1 μM) and CNQX
(10 μM) to block action potentials and glutamatergic
responses, respectively. We have previously shown that
THIP at micromolar concentrations elicited a tonic current
(10–30 pA) in hippocampal neurons [34]. Here, we found
that application of 5 μM THIP had no significant effect
on both the mIPSC amplitude (control, 18.9 ± 1.1 pA,
n = 12; THIP, 18.3 ± 1.3 pA, n = 12; p > 0.6) and the
frequency (control, 0.76 ± 0.18 Hz, n = 12; THIP, 0.96 ±
0.30 Hz, n = 12; p > 0.4) (Figure 6). We did notice that the
baseline noise in the presence of THIP was always larger
than the controls, indicating the tonic activation of
extrasynaptic GABAA-Rs by low concentration of THIP.
Figure 6 THIP at low concentration has no effect on the
amplitude and frequency of mIPSCs. A, B, Representative traces
showing mIPSCs recorded in control and THIP (5 μM) treated neurons.
Note that in the presence of THIP, baseline was always noisier than
control traces, indicating the activation of extrasynaptic GABAA-Rs. C, D,
No significant difference between the mIPSC amplitude (p > 0.6) and
frequency (p > 0.4) in control and THIP-treated neurons.
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synaptic GABAA-Rs are not significantly affected at this
low concentration of THIP.
Mechanism of tonic inhibition in modulating neuronal
activity
We next examined the effect of THIP on neuronal activity
at basal level as well as under stimulated conditions. InFigure 7 THIP effect on basal and elevated neuronal activity. A, B, THI
(p > 0.4, n = 12). C, D, THIP significantly inhibited CTZ-induced action pote
potentials (p < 0.03, n = 10).normal bathing solution, application of low concentra-
tion of THIP (5 μM) showed no significant effect on ac-
tion potential firing in the majority of neurons tested
(Figure 7A-B; control, 0.055 ± 0.015 Hz; THIP, 0.050 ±
0.013 Hz; n = 12, p > 0.4, paired t test). However, when
neuronal activity was elevated by CTZ (5 μM) as dem-
onstrated previously [36], THIP exerted a significant in-
hibitory effect on neuronal activity (Figure 7C-D).
Action potential firing frequency dropped significantly
from 0.152 ± 0.027 Hz under CTZ application to 0.092 ±
0.022 Hz when THIP was applied together with CTZ
(n = 17, p < 0.01, paired t test). To confirm that THIP
has greater effect when neuronal activity is elevated,
we further stimulated neurons with low concentration
of kainic acid (KA). Bath application of KA (2.5 μM)
induced a large membrane depolarization and a re-
markable increase of action potential firing (Figure 7E).
Importantly, co-application of 5 μM THIP together
with KA significantly decreased the firing frequency in all
of the neurons recorded (Figure 7E-F; KA, 1.4 ± 0.4 Hz;
KA+THIP, 0.6 ± 0.1 Hz; n = 10, p < 0.03, paired t test).
Together, our results suggest that tonic inhibition may
have greater modulatory effect on neural networks with
hyperexcitatory activity, such as that under epileptogenic
stimulation, making extrasynaptic GABAA-Rs ideal for de-
veloping novel anti-convulsant drugs.
Discussion
In this study, we have demonstrated that two distinct
subtypes of extrasynaptic GABAA-Rs both play an im-
portant role in regulating the formation of epileptiformP had no significant effect on the basal level of action potential firing
ntials (p < 0.01, n = 17). E, F, THIP also inhibited KA-induced action
Sun et al. Molecular Brain 2013, 6:21 Page 9 of 13
http://www.molecularbrain.com/content/6/1/21activity in hippocampal cultures. Enhancing tonic inhib-
ition in living animals in vivo also modulates epileptiform
activity and behavioral seizures in a dose-dependent man-
ner. More importantly, we demonstrated that tonic inhib-
ition potently inhibits high frequency action potentials
under stimulated conditions but not at basal low fre-
quency firing condition, suggesting a novel mechanism of
tonic inhibition in regulating neural network activity.
Extrasynaptic GABAA-Rs regulate epileptogenesis
Due to its continuous activation by ambient GABA, the
charge transfer of tonic currents mediated by extrasynaptic
GABAA-Rs have been estimated to be several folds more
than phasic currents mediated by synaptic GABAA-Rs
[4,45,46]. Tonic GABA conductance controls the overall
gain of neuronal input–output [5,45-48]. Therefore, when
GABAA receptor α5 and δ subunits were found signifi-
cantly reduced in the hippocampus of animal TLE models
[8,25,49,50], it was realized that downregulation of tonic
inhibition might have contributed to epileptogenesis.
Consistently, our previous work has also demonstrated
that tonic GABA inhibition was downregulated after
chronic epileptogenic stimulation in cultured hippo-
campal neurons [34]. However, later studies found that
despite a reduction of α5 and δ subunit expression in
epileptic mice, tonic inhibition in the hippocampus was
largely maintained or even increased, possibly mediated
by increased expression of α4γ2-containing GABAA-Rs
[26,28,32]. Thus, tonic inhibition might have undergone
homeostatic changes during and after epileptogenesis
[51]. Our current study demonstrated that enhancing
tonic inhibition by increasing the expression level of ei-
ther α5β3γ2 or α6β3δ receptors can effectively suppress
epileptiform activity. We have further demonstrated
that seizure behaviors are attenuated by enhancing tonic
inhibition in vivo. Based on previous and our own studies,
we attribute an important role to tonic inhibition in
modulating hippocampal epileptogenesis: enhancing tonic
inhibition will inhibit epileptiform activity, while reducing
tonic inhibition will increase the susceptibility of epileptic
seizures [31,44].
Overexpression of extrasynaptic GABAA-Rs regulates
epileptiform activity
While THIP has been used previously to modulate epi-
leptiform activity, the target receptors were usually not
specifically identified because higher concentrations of
THIP might activate different combinations of synaptic
and extrasynaptic GABAA-Rs. Our current study pro-
vides more direct evidence on extrasynaptic regulation
of epileptogenesis by demonstrating that overexpression
of both α5β3γ2 and α6β3δ receptors can effectively
attenuate epileptiform activity. We showed that neurons
transfected with both α5β3γ2 and α6β3δ receptors hadenhanced tonic currents compared to control neurons.
Mutations in the δ subunit of GABAA receptors have
been mapped in human epilepsy patients [29,30], indi-
cating the clinical relevance of δ-GABAA receptors. Our
molecular expression studies suggest that extrasynaptic
GABAA-Rs may be a potential therapeutic target for
developing antiepileptic drugs to treat TLE.
THIP regulation of neuronal activity
Previous studies have reported that THIP may inhibit
neuronal activity [52-56]. However, these studies used
concentrations much higher than our current work. It is
known that high concentration of THIP may directly
activate γ2-containing synaptic GABAA-Rs [42,57,58]. In
this study, we used a low concentration of THIP (5 μM)
that did not affect mIPSCs, indicating that at this con-
centration THIP did not activate synaptic GABAA-Rs.
Correspondingly, we found that 5 μM THIP did not
affect basal neuronal firing in the majority of neurons
tested. More importantly, we discovered a strong inhibi-
tory effect of THIP on elevated neuronal activity induced
by both CTZ and KA. It is possible that elevated neur-
onal activity may induce substantial release of GABA
[46], which will act together with THIP to enhance tonic
inhibition and reduce neuronal activity. Another possi-
bility is that tonic current may be outward rectifying at
depolarized membrane potential [59], making the effect
of THIP more potent when neurons are hyperexcitatory.
Our discovery of the preferential inhibition of THIP on
elevated activity makes it an ideal candidate for anticon-
vulsant drug, because it may have less side effects com-
paring to those affecting basal neural activity.
Conclusions
We employed both molecular and pharmacological
tools to demonstrate that tonic inhibition modulates
epileptiform activity both in vitro and in vivo. The
overexpression of both α5β3γ2 and α6β3δ receptors
inhibited the formation of epileptiform activity in hip-
pocampal neurons, establishing unambiguously a solid
ground for extrasynaptic modulation of epileptogenesis.
Furthermore, we discovered a more prominent role of
tonic inhibition in inhibiting hyperexcitatory activity ra-
ther than low frequency basal activity, suggesting that
extrasynaptic GABAA-Rs are ideal drug targets for de-
veloping anti-convulsant drugs that may specifically act
against epileptiform activity without much side effect
on normal brain functions.
Methods
Primary neuronal culture
Primary hippocampal neurons were prepared from em-
bryonic day 18 Sprague–Dawley rat embryos of either
sex, similar to our previous work with modifications
Sun et al. Molecular Brain 2013, 6:21 Page 10 of 13
http://www.molecularbrain.com/content/6/1/21[34]. Briefly, after dissection of the hippocampi, the tis-
sue was rinsed in cold HBS and then digested with
0.05% trypsin-EDTA for 20 min at 37°C, followed by trit-
uration with pipettes in the plating medium (DMEM
with 10% FBS and 10% F12). After rinsing for twice, cells
were counted and plated onto coverslips precoated with
0.1 mg/ml poly-D-lysine (Sigma). After culturing for 1
day, media were changed into neuronal culture media
(neurobasal media containing 2 mM GlutaMAX™-I Sup-
plement and 2% B-27). AraC (1 μM, Sigma) was added
6–8 days after plating, and cells were fed twice weekly
thereafter and maintained at 37°C and in 5% CO2 incu-
bators. Trypsin-EDTA, DMEM, FBS, F12, Neurobasal
media, GlutaMAX™-I Supplement and B-27 were pur-
chased from Invitrogen Corporation. Some experiments
were also performed using mouse hippocampal cultures.
DNA transfection
Calcium-phosphate transfection was performed similar
to the protocol previously described [60]. Neurons were
transfected at 10 days in vitro (DIV). The plasmids of rat
α5, α6, β3, γ2, δ subunits of GABAA receptors (gifts
from Drs. Robert Macdonald, Matthias Kneussel, and
Dr. Bernhard Luscher) were co-transfected with pEGFP or
mCherry (Clontech). Transfection with EGFP or mCherry
alone served as controls. Most of the experiments were
performed around 2 weeks of culture unless otherwise
indicated.
Electrophysiological recordings in cultured hippocampal
neurons
Whole-cell recordings were performed in current- or
voltage-clamp mode using a MultiClamp 700B amplifier
(Axon Instruments). Patch pipettes were pulled from
borosilicate glass (Sutter Instrument, BF150-86-10) and
fire polished (4–6 MΩ). The recording chamber was
continuously perfused with a bath solution consisting of
(mM): 128 NaCl, 30 Glucose, 25 Hepes, 5 KCl, 2 CaCl2,
1 MgCl2, pH 7.3 adjusted with NaOH. The pipette solution
for recording action potentials and mEPSCs contained
(mM): 125 K-gluconate, 10 KCl, 5 EGTA, 10 Hepes, 10
Tris-phosphocreatine, 4 MgATP, 0.5 NaGTP, pH 7.3
adjusted with KOH. For tonic GABA currents and GABA-
induced whole-cell currents, patch pipettes were filled with
(mM): 135 KCl, 10 Tris-phosphocreatine, 2 EGTA, 10
Hepes, 4 MgATP, 0.5 NaGTP, pH 7.3 adjusted with KOH.
Liquid junction potentials were always corrected before
forming giga-ohm seal. The series resistance was typic-
ally 10–20 MΩ and partially compensated by 30-50%.
Data were acquired using pClamp 10.2 software (Axon
Instruments), sampled at 2–10 kHz, and filtered at 1 kHz.
Off-line analysis was done with Clampfit 10.2 software
(Axon Instruments). Miniature events were analyzed using
Mini Analysis software (Synaptosoft). Large depolarizationshift resembling paroxysmal depolarization shift is defined
here as ≥ 10 mV depolarization and ≥ 300 ms in duration.
An epileptiform burst is defined by at least five con-
secutive action potentials overlaying on top of the large
depolarization shift. When quantifying the percentage
of neurons showing epileptiform activity, the criterion
is at least two epileptiform bursts occurring during 10
min of recording. All of the drugs used were freshly
diluted in bath solution to their final concentrations
before experiments.
Electrophysiological recordings in anaesthetized rats
Adult male Sprague–Dawley rats weighing between
250–350 g were maintained on an ad libitum feeding
schedule and kept on a 12 hr on/off light cycle. During
electrophysiological study, rats were anesthetized with
urethane (1.2 g/kg, i.p.) and the level of anesthesia was
assessed by the absence of a withdrawal reflex, and add-
itional anesthetic (urethane, 0.2-0.6 mg/kg, i.p.) was admin-
istered as necessary. Body temperature was maintained
at 37 ± 0.5°C with a Harvard Homoeothermic Blanket
(Harvard Apparatus Limited, Kent, UK). At the end of
experiments, animals were killed with an overdose of
urethane. All animal experiments were approved by the
local committee of Laboratory Animals, Fudan University
and carried out in accordance with Chinese National
Science Foundation animal research regulation. Animal
preparation was similar to previously reported [36,37,39].
Briefly, all the animals had their lateral tail vein cannulated
for drug administration and then mounted in a stereotaxic
frame. An incision was made in the midline of the head
to expose the top part of the skull for the implantation
of i.c.v. guide cannula (22GA, Plastics One, USA) into
the lateral ventricle (0.3 mm posterior to bregma, 1.3 mm
lateral to the midline, and 4 mm below the skull surface),
and then secured by the dental cement. For recording and
stimulating, a large burr hole was made in the left side of
the incised skull above the hippocampal area, and the dura
was pierced and removed. A concentric bipolar stimulat-
ing electrode (Harvard Apparatus) was placed close to the
CA3 region (3.8-4.5 mm posterior to bregma, 3.5-4.0 mm
lateral to the midline, and 3.0-3.8 mm below the brain sur-
face) in order to stimulate the Shaffer collateral pathway.
For recording in the CA1 pyramidal cell layer, a tungsten
electrode (0.5 MΩ, WPI, USA) was placed 3.5-4.2 mm
posterior to bregma, 2.0-3.0 mm lateral to the midline.
The depth of the recording electrode was approximately
2.0-2.5 mm below the brain surface as determined by
the sudden change of electrical noise and the shape of
the evoked field excitatory postsynaptic potentials
(fEPSPs) and population spike (PS). For stimulation, a
constant current generator passed a square-wave pulse
(0.2 ms in duration) through the stimulating electrode
(test pulse) and the stimulation frequency was set at
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amplified and filtered (0.3-3 kHz) using a NeuroLog
System (Digitimer Ltd., Hearts, UK) and visualized and
stored in a PC computer through an A-D converter, CED
1401 micro (Cambridge Electronic Design, Cambridge,
UK). After both electrodes were in the right place, the
fEPSPs and PS were monitored for at least 30 min until a
stable recording was achieved. Following a 30 min baseline
recording, CTZ (5 μmol, 5 μL) was administered i.c.v. via
the pre-implanted guide cannula into the left lateral ven-
tricle. Pharmacologically induced seizure-like activity was
monitored after CTZ injection by observing the change of
the evoked potentials transforming from single PS into a
multi-peaked display, and spontaneous seizure burst activ-
ity in CA1 pyramidal neurons [37,39,61]. After the epilep-
tiform burst activity was stable for at least 30 min, THIP
(4 mg/kg in 1 mL/kg) or vehicles were delivered through
the cannula pre-implanted in the lateral tail vein. To con-
firm correct placement of the electrode and cannula, the
brain was taken for histological validation of the injection
and recording/stimulating sites. Epileptiform activity
within CA1 pyramidal cells was analyzed offline using
Spike2 software (an analyzing program for CED 1401,
Cambridge Electronics, UK) and specific scripts designed
for this study with Spike2. The highly synchronized burst-
ing activity was defined as having high frequency multiple
high amplitude spikes (>0.5 mV) with an initial interspike
interval of less than 0.1 s, a minimum of 5 spikes, and
burst duration over 1 s [37].
Behavioral test in freely moving rats
CTZ induced seizure behavioral test was carried out
similarly as previously reported [38]. Briefly, under general
anesthetics with sodium pentobarbital (60 mg/kg, i.p.), a
guide cannula was pre-implanted into left lateral ventricle
(0.3 mm posterior to bregma, 1.3 mm lateral to the mid-
line, and 4 mm below the skull surface) at least 5 days
before the behavioral test. Cannula-implanted animals
were randomly divided into following experimental
groups: 1) CTZ group: 0.25 μmol (i.c.v.) for one injec-
tion per day, three consecutive days; 2) THIP + CTZ
group one: 5 mg/kg (i.p.) THIP + 0.25 μmol (i.c.v.) CTZ
for one injection per day, three consecutive days; 3)
THIP + CTZ group two: 10 mg/kg (i.p.) THIP + 0.25
μmol (i.c.v.) CTZ for one injection per day, three con-
secutive days. All behavioral tests were carried out be-
tween 2:00 pm and 7:00 pm. The animals were first
placed in a plastic cage and acclimatized for at least half
an hour before experiments. Before and after drug injec-
tion, animal behavior was continuously monitored for a
period of 1 and 3 hours with video recording, respect-
ively. Behavioral seizures were scored using 5-graded
Racine Score system [62]. Briefly, Racine score I, facial
clonus; score II, head nodding; score III, unilateralforelimb clonus; score IV, rearing with bilateral forelimb
clonus; score V, rearing and falling (loss of postural
control).
Data analysis
Group data were expressed as mean ± SEM. Across differ-
ent groups of data, statistical significance between means
was determined using one-way ANOVA with Tukey HSD
post hoc analysis. Comparison within a group used a
paired or unpaired t test (GraphPad Prism, GraphPad
Software Inc.). Pearson Chi-Square test was used for stat-
istical analysis of percentage (SPSS). Significance level was
set at p < 0.05.
Drugs and solutions
Cyclothiazide (CTZ) and L655708 were purchased
from Tocris (Northpoint, Bristol). THIP (4,5,6,7-tetra-
hydroisoxazolo[4,5-c] pyridine-3-ol and urethane (25%
in distilled water) were purchased from Sigma Aldrich
Chemical Co. (Poole, Dorset).
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